This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Azathioprine during pregnancy

Authoring team

  • Pregnancy and lactation - limited data suggests that if a woman becomes pregnant while taking a thiopurine for inflammatory bowel disease, continuing treatment does not increase the risks of pregnancy complications or congenital abnormalities. However, it seems prudent not to start a thiopurine if a woman plans to become, or is, pregnant, nor should women breast feed- while taking a thiopurine (1).
  • there is evidence suggestive of an increased risk of congenital abnormalilty and spontaneous abortion if the father has received treatment with a thiopurine within 3 months of the baby being conceived (2)

Reference:

  1. Drugs and Therapeutics Bulletin (2002), 39 (12), 91-95.
  2. Rajapske RO et al (2000). Outcomes of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol, 95, 292-7.

 

 


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.